Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it compare to its competitors? We will compare Cytek Biosciences to similar companies based on the strength of its earnings, profitability, risk, institutional ownership, analyst recommendations, valuation and dividends. Analyst Recommendations This is a breakdown […]